Pfizer CEO unveils 2030 growth plan as company faces up to $18 billion in generic drug sales slump – CNBC | NutSocia

Albert Bourla, CEO of Pfizer, speaks during a news conference with the President of the European Commission after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at U.S. pharmaceutical company Pfizer’s Puurs factory April 23, 2021. Johannes Thys | AFP | Getty Images Pfizer CEO Albert Bourla on Tuesday laid out his … Read more